FOR IMMEDIATE RELEASE
Medidata Solutions Senior Vice President of
Development Named to PharmaVOICE 100
Andrew Newbigging Recognized for Driving
Innovation in Clinical Technology Integration
NEW YORK, N.Y. – August 3, 2011 – Medidata Solutions (NASDAQ: MDSO), a leading global provider of SaaS-based clinical development solutions, today announced that senior vice president of development Andrew Newbigging has been honored by PharmaVOICE magazine as one of the 100 most inspiring people in the life sciences industry.
Over the last five years, Andrew has been a driving force in Medidata’s industry-leading and redefining effort to bring interoperability across clinical development solutions. His global team, made up of 80 software engineers across the UK, US and Japan, has architected Medidata products, including the Medidata Rave® electronic data capture and clinical data management system, to facilitate the seamless flow of data with a range of other critical clinical technologies. As a result, sponsors around the globe benefit from faster access to clinical and operational data, supporting improved decision making and a streamlined end-to-end clinical research process.
Through Andrew’s expertise and innovation, Medidata introduced the industry’s first developer community designed to facilitate clinical system interoperability, Medidata Developer Central, which supports integration efforts using Medidata’s Web Services APIs. Encouraging collaborative innovation in the industry, Developer Central today has members from more than 100 organizations. Andrew also led Medidata to attain a series of CDISC certifications that resulted in Medidata being the first company to be fully CDISC certified for all eight operational data model (ODM) use cases.
“Thanks to Andrew’s expertise and commitment, the Medidata platform is considered to have one of the industry’s most robust integration architectures, allowing for interfaces with the diverse clinical infrastructure within our customers’ and partners’ clinical environments,” said Glen de Vries, president, Medidata Solutions. “We have no doubt that Andrew will continue to inspire others as he applies his passion for software as a service, cloud computing and creating applications that people love to use.”
Established seven years ago by PharmaVOICE magazine, the PharmaVOICE 100 is an annual list of individuals recognized for their positive contributions to the life sciences industry. Nominated by thousands of PharmaVOICE readers, the PharmaVOICE 100 are selected based on well-crafted and comprehensive essays describing how individuals inspired or motivated them or affected positive changes, as well as other factors, such as community and philanthropic activities. The PharmaVOICE 100 represent a broad cross section of industry sectors, including pharmaceutical, biopharmaceutical, biotechnology, contract research, clinical trial, research and development, patient education, patient recruitment, advertising, technology and many others.
“The PharmaVOICE 100 are individuals who think outside the box, pioneer new paths to success, and inspire their colleagues in the industry; they translate industry issues into opportunities and take the time to mentor the next generation of leaders in the life sciences arena,” said Taren Grom, editor-in-chief and cofounder of PharmaVOICE. “We are extremely pleased to recognize these 100 individuals in the July/August issue.”
About PharmaVOICE
PharmaVOICE is expressly written and designed to deliver the views, opinions, and insights of executives who are shaping the direction of the dynamic life-sciences industry. PharmaVOICE reaches more than 17,500 readers every month in print and more than 65,000 through its online version, which contains original exclusive bonus content. PharmaVOICE’s unique horizontal editorial approach cuts industry silos, providing a holistic overview of the life-sciences industry, addressing a range of topics from molecule through market. By engaging compelling personalities from diverse industry sectors, PharmaVOICE provides multiple perspectives on business challenges, trends, and topics. Editorial content sparks dialog, initiates debate, and opens the lines of communication to facilitate and improve business-to-business relationships. PharmaVOICE’s multiple-perspective and in-depth original forums, feature articles, topics, and departments are audience-driven. PharmaVOICE provides executives with useful peer-to-peer insights on a broad range of life sciences business practices and topics.
About Medidata Solutions Worldwide
Medidata Solutions is a leading global provider of SaaS clinical development solutions that enhance the efficiency of customers’ clinical trials. Medidata’s advanced solutions lower the total cost of clinical development by optimizing clinical trials from concept to conclusion: from study and protocol design, trial planning and budgeting, site negotiation, clinical portal, trial management, randomization and trial supply management, clinical data capture and management, safety events capture, medical coding to business analytics. Our diverse life science customer base spans biopharmaceutical companies, medical device and diagnostic companies, academic and government institutions, CROs and other research organizations, and includes more than 20 of the top 25 global pharmaceutical companies as well as organizations of all sizes developing life-enhancing medical treatments and diagnostics.
Contact:
Susan McCarron
Lois Paul & Partners
781.782.5767
Susan_McCarron@lpp.com